Research Guide
How to read biotech cash runway
Cash runway determines whether a company can reach its next value-changing milestone without dilutive financing. The important question is whether the cash balance matches the clinical plan and catalyst timeline.
What to check first
Start with the evidence that can change value: clinical relevance, regulatory path, competitive context, financing needs, and whether the company can reach the next milestone.
How Drugnews uses this guide
We apply these frameworks when writing company research, paid analysis, and client-facing content so that readers can follow the logic behind each judgment.